Rep. Dan Newhouse Sells Off Shares of Danaher Co. (NYSE:DHR)

Representative Dan Newhouse (R-Washington) recently sold shares of Danaher Co. (NYSE:DHR). In a filing disclosed on May 16th, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on April 11th. The trade occurred in the Representative’s “EDWARD JONES IRA” account.

Representative Dan Newhouse also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of PayPal (NASDAQ:PYPL) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Moody’s (NYSE:MCO) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of NVIDIA (NASDAQ:NVDA) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Dollar General (NYSE:DG) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Lowe’s Companies (NYSE:LOW) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of BlackRock (NYSE:BLK) on 4/11/2025.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 4/11/2025.

Danaher Stock Performance

Shares of NYSE DHR traded down $2.69 during midday trading on Monday, hitting $184.79. 2,814,188 shares of the company’s stock were exchanged, compared to its average volume of 3,475,339. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $132.25 billion, a PE ratio of 35.00, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company’s 50 day moving average price is $195.01 and its 200 day moving average price is $215.27.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.69%. Danaher’s dividend payout ratio (DPR) is 24.85%.

Insiders Place Their Bets

In other news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent analyst reports. Royal Bank of Canada reiterated an “outperform” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. lowered their target price on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a report on Tuesday, April 22nd. UBS Group lowered their target price on Danaher from $275.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Barclays increased their price target on Danaher from $205.00 to $215.00 and gave the company an “overweight” rating in a research note on Tuesday, April 22nd. Finally, HSBC cut their target price on Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $263.24.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of DHR. Kentucky Retirement Systems Insurance Trust Fund increased its position in shares of Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock valued at $4,874,000 after acquiring an additional 2,202 shares during the last quarter. FAS Wealth Partners Inc. boosted its holdings in shares of Danaher by 20.6% in the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate’s stock worth $2,203,000 after acquiring an additional 1,639 shares during the period. Generate Investment Management Ltd bought a new stake in Danaher during the fourth quarter valued at $8,044,000. Compass Capital Management Inc. boosted its stake in Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock valued at $54,615,000 after buying an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC boosted its stake in Danaher by 42.8% during the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate’s stock valued at $1,301,000 after buying an additional 1,698 shares during the period. Institutional investors own 79.05% of the company’s stock.

About Representative Newhouse

Dan Newhouse (Republican Party) is a member of the U.S. House, representing Washington’s 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.

Newhouse (Republican Party) ran for re-election to the U.S. House to represent Washington’s 4th Congressional District. He won in the general election on November 5, 2024.

Click here to see Newhouse’s key votes in Congress.

Newhouse served as a member of the Washington House of Representatives representing District 15-Position 2 from 2003 through 2009 and as Washington Director of Agriculture from 2009 to 2013.

Newhouse was first elected to the state House in 2002 and served until he was named state Director of Agriculture in 2009. He was first appointed by Governor Christine Gregoire on February 18, 2009.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.